Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…